Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q3 2024 · 10-Q
Revenue$63.67M$63.67M+11.2% vs Q3 2023 Net Income-$2.03M-$2.03MN/M vs Q3 2023 EPS Diluted-$0.10-$0.10N/M vs Q3 2023 Gross Profit$19,424,000+17.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived-$2,593,000N/M Free Cash Flowderived-$3,716,000N/M Margins · derivedGross margin30.5%+1.6 pt vs Q3 2023
Operating margin-4.8%−3.5 pt vs Q3 2023
Net margin-3.2%−2.8 pt vs Q3 2023
ended Dec 31, 2023 · filed Apr 15, 2024 · 106 d after period end